title: Predilatation of the cervix before suction curettage for therapeutic abortion in early pregnancy.
abstract: The oral use of a synthetic methyl ester analogue of prostaglandin E1 (misoprostol) prior to suction curettage for therapeutic abortion in early pregnancy is reported. Misoprostol was found to be an effective, inexpensive and safe agent for preoperative cervical treatment.
authors.affiliation: Lyndhurst Hospital, Christchurch, New Zealand.
authors.forename: D
authors.initials: D
authors.lastname: Edwards
authors.forename: R E
authors.initials: RE
authors.lastname: Aitken
authors.forename: A F
authors.initials: AF
authors.lastname: Begg
authors.forename: P M
authors.initials: PM
authors.lastname: MacKay
authors.forename: R M
authors.initials: RM
authors.lastname: Marchant
mesh_terms: D000032:Abortion, Therapeutic; D000284:Administration, Oral; D000328:Adult; D002584:Cervix Uteri / Q000187:drug effects*; D004106:Dilatation; D005260:Female; D006801:Humans; D016595:Misoprostol / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D014619:Vacuum Curettage
chemical_list: D016595:Misoprostol